Possible Protective Effects of TA on the Cancerous Effect of Mesotrione

Agata Jabłońska-Trypuć1, Urszula Wydro1, Elżbieta Wołejko1

  • 1Division of Chemistry, Biology and Biotechnology, Faculty of Civil Engineering and Environmental Sciences, Bialystok University of Technology, 15-351 Białystok, Poland.

Nutrients
|May 14, 2020
PubMed

Insights

Traumatic acid (TA) can inhibit cancer cell growth stimulated by the herbicide mesotrione. TA exhibits pro-oxidative and pro-apoptotic effects on cancer cells, suggesting potential cytoprotective functions against herbicide-induced proliferation.

Area of Science:

  • Food science
  • Toxicology
  • Oncology

Background:

  • Pesticides and their byproducts are common food contaminants linked to increased cancer incidence.
  • Traumatic acid (TA), a plant-derived compound, shows differential antioxidant/pro-oxidant activity in normal vs. cancer cells.
  • Previous research indicated TA's pro-oxidant activity in cancer cells.

Purpose of the Study:

  • To investigate if traumatic acid (TA) can counteract the cancer cell growth-promoting effects of the herbicide mesotrione.
  • To assess the cytotoxicity of mesotrione and TA, individually and in combination, on breast cancer cells.
  • To analyze the impact of TA and mesotrione on oxidative stress and apoptosis in ZR-75-1 cells.

Main Methods:

  • Cytotoxicity studies were performed using environmentally relevant concentrations of mesotrione and TA.
  • Combinations of mesotrione and TA were tested on ZR-75-1 breast cancer cells.
  • Oxidative stress markers and apoptosis were analyzed in treated cells.

Main Results:

  • Traumatic acid (TA) demonstrated the ability to inhibit the growth of ZR-75-1 cells stimulated by mesotrione.
  • TA induced oxidative stress and apoptosis in ZR-75-1 cancer cells.
  • The findings suggest TA has pro-oxidative and pro-apoptotic effects on mesotrione-stimulated cancer cells.

Conclusions:

  • Traumatic acid (TA) can inhibit the proliferation of breast cancer cells when their growth is enhanced by mesotrione.
  • TA's pro-oxidative and pro-apoptotic properties in cancer cells suggest a potential role in mitigating herbicide-induced proliferation.
  • These results may inform the understanding of herbicide risks in cancer patients and the potential therapeutic applications of TA.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.7K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
721
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K